Correlation Between OBI Pharma and Swancor Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OBI Pharma and Swancor Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OBI Pharma and Swancor Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OBI Pharma and Swancor Holding Co, you can compare the effects of market volatilities on OBI Pharma and Swancor Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OBI Pharma with a short position of Swancor Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of OBI Pharma and Swancor Holding.

Diversification Opportunities for OBI Pharma and Swancor Holding

0.91
  Correlation Coefficient

Almost no diversification

The 3 months correlation between OBI and Swancor is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding OBI Pharma and Swancor Holding Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Swancor Holding and OBI Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OBI Pharma are associated (or correlated) with Swancor Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Swancor Holding has no effect on the direction of OBI Pharma i.e., OBI Pharma and Swancor Holding go up and down completely randomly.

Pair Corralation between OBI Pharma and Swancor Holding

Assuming the 90 days trading horizon OBI Pharma is expected to generate 0.54 times more return on investment than Swancor Holding. However, OBI Pharma is 1.86 times less risky than Swancor Holding. It trades about -0.16 of its potential returns per unit of risk. Swancor Holding Co is currently generating about -0.17 per unit of risk. If you would invest  6,130  in OBI Pharma on September 15, 2024 and sell it today you would lose (270.00) from holding OBI Pharma or give up 4.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy95.65%
ValuesDaily Returns

OBI Pharma  vs.  Swancor Holding Co

 Performance 
       Timeline  
OBI Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OBI Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Swancor Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Swancor Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

OBI Pharma and Swancor Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OBI Pharma and Swancor Holding

The main advantage of trading using opposite OBI Pharma and Swancor Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OBI Pharma position performs unexpectedly, Swancor Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Swancor Holding will offset losses from the drop in Swancor Holding's long position.
The idea behind OBI Pharma and Swancor Holding Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements